本页面由Tiger Trade Technology Pte. Ltd.提供服务

Agios Pharmaceuticals, Inc.

28.00
-0.0500-0.18%
盘后28.000.00000.00%19:06 EDT
成交量:130.60万
成交额:3,669.29万
市值:16.65亿
市盈率:-3.93
高:28.68
开:28.07
低:27.71
收:28.05
52周最高:46.00
52周最低:22.24
股本:5,947.16万
流通股本:5,061.86万
量比:0.97
换手率:2.58%
股息:- -
股息率:- -
每股收益(TTM):-7.1203
每股收益(LYR):-7.1203
净资产收益率:-30.20%
总资产收益率:-19.94%
市净率:1.40
市盈率(LYR):-3.93

数据加载中...

2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities